Share Price and Basic Stock Data
Last Updated: January 8, 2026, 5:24 pm
| PEG Ratio | 1.33 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Continental Seeds and Chemicals Ltd operates within the seeds, tissue culture, and biotechnology industry, with the stock price currently at ₹22.2 and a market capitalization of ₹30.4 Cr. The company has shown fluctuating revenue trends in its quarterly sales. For instance, sales peaked at ₹62.65 Cr in March 2020, before declining to ₹39.24 Cr in September 2023. The revenue for the trailing twelve months (TTM) stood at ₹67.79 Cr, reflecting a significant decrease from the ₹97.88 Cr reported in March 2022. Year-on-year comparisons reveal that total sales for the fiscal year ending March 2024 were ₹97.68 Cr, a recovery from the ₹75.41 Cr recorded in March 2023. However, the sales forecast for March 2025 is projected to be lower at ₹90.75 Cr. The company’s sales performance has been inconsistent, with quarterly fluctuations indicating sensitivity to market conditions and operational challenges.
Profitability and Efficiency Metrics
Continental Seeds and Chemicals Ltd reported a net profit of ₹0.85 Cr, with a profit margin of 2.01% for the fiscal year ending March 2025. The operating profit margin (OPM) has shown improvement, rising to 8.85% as of September 2025, compared to a negative OPM of -0.06% in March 2024. This positive trend reflects enhanced operational efficiency, despite the challenges faced in previous quarters. The interest coverage ratio (ICR) is robust at 8.99x, indicating the company’s ability to meet interest obligations comfortably. However, the return on equity (ROE) remains low at 2.87%, suggesting limited returns on shareholders’ investments. Furthermore, the return on capital employed (ROCE) is reported at 4.24%, indicating that capital is not being utilized effectively compared to industry standards. Overall, while profitability metrics show signs of recovery, the company must address underlying inefficiencies to enhance returns further.
Balance Sheet Strength and Financial Ratios
The balance sheet of Continental Seeds and Chemicals Ltd reflects a cautious financial approach, with total borrowings of ₹3.72 Cr against reserves of ₹16.46 Cr, resulting in a debt-to-equity ratio of 0.11. This indicates a low reliance on debt financing, which is favorable in uncertain market conditions. The current ratio stands at 2.82, signaling strong liquidity and the ability to cover short-term obligations. The price-to-book value (P/BV) ratio is reported at 1.30x, suggesting the stock may be fairly valued relative to its book value. Furthermore, the company’s cash conversion cycle (CCC) has increased to 64.99 days, indicating a longer period to convert investments in inventory and accounts receivable into cash. This prolonged cycle may impact liquidity in the short term. The overall financial ratios indicate that while the company maintains solid liquidity and low leverage, it must improve efficiency to enhance operational cash flows.
Shareholding Pattern and Investor Confidence
As of October 2025, the shareholding pattern of Continental Seeds and Chemicals Ltd shows that promoters hold a significant 60.06% stake, down from 72.27% in September 2022. This decline may raise concerns regarding insider confidence, especially given that foreign institutional investors (FIIs) have increased their stake to 12.41%, compared to zero earlier in the year. Public shareholding stands at 27.54%, reflecting a stable investor base. The increase in public shareholders from 306 in September 2022 to 371 in October 2025 indicates growing interest in the stock. However, the drop in promoter holding may suggest a shift in strategy or a response to market pressures. The overall investor confidence appears mixed; while institutional interest is rising, the reduction in promoter ownership may lead to apprehensions among retail investors regarding the company’s future direction.
Outlook, Risks, and Final Insight
The outlook for Continental Seeds and Chemicals Ltd hinges on its ability to stabilize revenue and enhance profitability amidst operational challenges. Key strengths include a solid balance sheet with low debt levels and improving operational efficiency, as evidenced by the rising OPM and ICR. However, the company faces risks such as fluctuating sales and a prolonged cash conversion cycle, which could strain liquidity. In a favorable scenario, if the company can leverage its low debt and improve operational efficiencies, it may enhance profitability and shareholder value. Conversely, if sales continue to decline or operational inefficiencies persist, the company could face significant challenges in sustaining its financial health. Overall, while the company demonstrates potential for recovery, addressing operational and market challenges will be critical for long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Genomic Valley Biotech Ltd | 7.94 Cr. | 26.0 | 94.0/21.0 | 79.4 | 12.8 | 0.00 % | 11.8 % | 9.69 % | 10.0 |
| Genesis IBRC India Ltd | 119 Cr. | 91.6 | 185/17.5 | 6.42 | 0.00 % | 51.6 % | 51.6 % | 10.0 | |
| Shreeoswal Seeds & Chemicals Ltd | 139 Cr. | 15.2 | 20.3/10.7 | 13.9 | 5.23 | 0.00 % | 9.88 % | 8.41 % | 2.00 |
| Nath Bio-Genes (India) Ltd | 293 Cr. | 154 | 239/138 | 6.21 | 362 | 1.30 % | 7.35 % | 6.77 % | 10.0 |
| Continental Seeds and Chemicals Ltd | 28.9 Cr. | 21.1 | 34.8/19.3 | 37.6 | 22.5 | 0.00 % | 4.24 % | 2.87 % | 10.0 |
| Industry Average | 183.67 Cr | 61.58 | 34.28 | 81.79 | 0.26% | 16.97% | 15.87% | 8.40 |
All Competitor Stocks of Continental Seeds and Chemicals Ltd
Quarterly Result
| Metric | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Sep 2022 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25.27 | 62.65 | 38.33 | 57.07 | 38.33 | 57.07 | 39.24 | 58.44 | 43.53 | 47.22 | 20.57 |
| Expenses | 24.72 | 61.78 | 37.65 | 56.36 | 37.65 | 56.36 | 37.57 | 60.18 | 42.16 | 45.80 | 18.75 |
| Operating Profit | 0.55 | 0.87 | 0.68 | 0.71 | 0.68 | 0.71 | 1.67 | -1.74 | 1.37 | 1.42 | 1.82 |
| OPM % | 2.18% | 1.39% | 1.77% | 1.24% | 1.77% | 1.24% | 4.26% | -2.98% | 3.15% | 3.01% | 8.85% |
| Other Income | 0.12 | 0.19 | 0.13 | 0.12 | 0.13 | 0.12 | 0.16 | 4.21 | 1.65 | 0.66 | 0.15 |
| Interest | 0.22 | 0.21 | 0.24 | 0.30 | 0.24 | 0.30 | 0.24 | 0.29 | 0.22 | 0.18 | 0.18 |
| Depreciation | 0.25 | 0.19 | 0.22 | 0.39 | 0.22 | 0.39 | 1.47 | 1.50 | 1.29 | 1.20 | 1.36 |
| Profit before tax | 0.20 | 0.66 | 0.35 | 0.14 | 0.35 | 0.14 | 0.12 | 0.68 | 1.51 | 0.70 | 0.43 |
| Tax % | 90.00% | 3.03% | 31.43% | 0.00% | 31.43% | 0.00% | -8.33% | 20.59% | 22.52% | 4.29% | 55.81% |
| Net Profit | 0.01 | 0.63 | 0.23 | 0.14 | 0.23 | 0.14 | 0.12 | 0.54 | 1.17 | 0.66 | 0.19 |
| EPS in Rs | 0.01 | 0.63 | 0.23 | 0.14 | 0.23 | 0.14 | 0.12 | 0.54 | 1.06 | 0.52 | 0.14 |
Last Updated: January 2, 2026, 1:37 am
Below is a detailed analysis of the quarterly data for Continental Seeds and Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 20.57 Cr.. The value appears to be declining and may need further review. It has decreased from 47.22 Cr. (Mar 2025) to 20.57 Cr., marking a decrease of 26.65 Cr..
- For Expenses, as of Sep 2025, the value is 18.75 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 45.80 Cr. (Mar 2025) to 18.75 Cr., marking a decrease of 27.05 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.82 Cr.. The value appears strong and on an upward trend. It has increased from 1.42 Cr. (Mar 2025) to 1.82 Cr., marking an increase of 0.40 Cr..
- For OPM %, as of Sep 2025, the value is 8.85%. The value appears strong and on an upward trend. It has increased from 3.01% (Mar 2025) to 8.85%, marking an increase of 5.84%.
- For Other Income, as of Sep 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.66 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.51 Cr..
- For Interest, as of Sep 2025, the value is 0.18 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.18 Cr..
- For Depreciation, as of Sep 2025, the value is 1.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.20 Cr. (Mar 2025) to 1.36 Cr., marking an increase of 0.16 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.43 Cr.. The value appears to be declining and may need further review. It has decreased from 0.70 Cr. (Mar 2025) to 0.43 Cr., marking a decrease of 0.27 Cr..
- For Tax %, as of Sep 2025, the value is 55.81%. The value appears to be increasing, which may not be favorable. It has increased from 4.29% (Mar 2025) to 55.81%, marking an increase of 51.52%.
- For Net Profit, as of Sep 2025, the value is 0.19 Cr.. The value appears to be declining and may need further review. It has decreased from 0.66 Cr. (Mar 2025) to 0.19 Cr., marking a decrease of 0.47 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.14. The value appears to be declining and may need further review. It has decreased from 0.52 (Mar 2025) to 0.14, marking a decrease of 0.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 54.56 | 57.69 | 58.07 | 58.19 | 81.62 | 82.10 | 87.68 | 95.36 | 97.88 | 75.41 | 97.68 | 90.75 | 67.79 |
| Expenses | 54.49 | 56.80 | 57.28 | 56.71 | 79.77 | 80.37 | 86.24 | 93.88 | 96.10 | 71.50 | 97.74 | 87.96 | 64.55 |
| Operating Profit | 0.07 | 0.89 | 0.79 | 1.48 | 1.85 | 1.73 | 1.44 | 1.48 | 1.78 | 3.91 | -0.06 | 2.79 | 3.24 |
| OPM % | 0.13% | 1.54% | 1.36% | 2.54% | 2.27% | 2.11% | 1.64% | 1.55% | 1.82% | 5.18% | -0.06% | 3.07% | 4.78% |
| Other Income | 0.30 | 0.09 | 0.06 | 0.05 | 0.09 | 0.10 | 0.31 | 0.26 | 0.24 | 0.16 | 4.37 | 2.30 | 0.81 |
| Interest | 0.00 | 0.36 | 0.52 | 0.62 | 0.62 | 0.70 | 0.45 | 0.64 | 0.39 | 0.53 | 0.54 | 0.40 | 0.36 |
| Depreciation | 0.08 | 0.24 | 0.10 | 0.20 | 0.26 | 0.27 | 0.44 | 0.61 | 1.25 | 3.52 | 2.97 | 2.49 | 2.56 |
| Profit before tax | 0.29 | 0.38 | 0.23 | 0.71 | 1.06 | 0.86 | 0.86 | 0.49 | 0.38 | 0.02 | 0.80 | 2.20 | 1.13 |
| Tax % | 27.59% | 31.58% | 26.09% | 33.80% | 32.08% | 45.35% | 25.58% | 22.45% | 47.37% | 50.00% | 16.25% | 16.82% | |
| Net Profit | 0.22 | 0.27 | 0.16 | 0.47 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.83 | 0.85 |
| EPS in Rs | 1.05 | 1.29 | 0.76 | 2.24 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.44 | 0.66 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 22.73% | -40.74% | 193.75% | 53.19% | -36.11% | 41.30% | -43.08% | -48.65% | -89.47% | 3250.00% | 173.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | -63.47% | 234.49% | -140.56% | -89.30% | 77.42% | -84.38% | -5.57% | -40.83% | 3339.47% | -3076.87% |
Continental Seeds and Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| TTM: | -7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 0% |
| 3 Years: | 41% |
| TTM: | 126% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 20% |
| 3 Years: | 40% |
| 1 Year: | -64% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | -2% |
| 3 Years: | -4% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:15 am
Balance Sheet
Last Updated: December 4, 2025, 1:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.25 | 1.25 | 1.25 | 1.25 | 6.00 | 6.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 12.70 | 13.20 |
| Reserves | 3.50 | 3.76 | 3.92 | 4.41 | 4.59 | 5.03 | 1.68 | 2.03 | 2.23 | 2.30 | 2.69 | 15.68 | 16.46 |
| Borrowings | 0.00 | 2.59 | 4.01 | 4.63 | 3.75 | 3.68 | 4.75 | 7.62 | 5.65 | 6.17 | 5.45 | 3.91 | 3.72 |
| Other Liabilities | 0.68 | 1.61 | 3.03 | 2.38 | 22.11 | 14.10 | 5.89 | 13.77 | 13.77 | 12.24 | 8.40 | 4.33 | 5.24 |
| Total Liabilities | 5.43 | 9.21 | 12.21 | 12.67 | 36.45 | 28.81 | 22.32 | 33.42 | 31.65 | 30.71 | 26.54 | 36.62 | 38.62 |
| Fixed Assets | 0.73 | 0.50 | 0.40 | 1.56 | 1.31 | 1.67 | 3.15 | 4.55 | 20.80 | 18.18 | 15.66 | 15.29 | 14.97 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.41 | 4.73 | 11.82 | 0.00 | 0.00 | 0.49 | 0.00 | 1.17 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.70 | 8.71 | 11.81 | 11.11 | 35.14 | 25.73 | 14.44 | 17.05 | 10.85 | 12.53 | 10.39 | 21.33 | 22.48 |
| Total Assets | 5.43 | 9.21 | 12.21 | 12.67 | 36.45 | 28.81 | 22.32 | 33.42 | 31.65 | 30.71 | 26.54 | 36.62 | 38.62 |
Below is a detailed analysis of the balance sheet data for Continental Seeds and Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.20 Cr.. The value appears strong and on an upward trend. It has increased from 12.70 Cr. (Mar 2025) to 13.20 Cr., marking an increase of 0.50 Cr..
- For Reserves, as of Sep 2025, the value is 16.46 Cr.. The value appears strong and on an upward trend. It has increased from 15.68 Cr. (Mar 2025) to 16.46 Cr., marking an increase of 0.78 Cr..
- For Borrowings, as of Sep 2025, the value is 3.72 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 3.91 Cr. (Mar 2025) to 3.72 Cr., marking a decrease of 0.19 Cr..
- For Other Liabilities, as of Sep 2025, the value is 5.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.33 Cr. (Mar 2025) to 5.24 Cr., marking an increase of 0.91 Cr..
- For Total Liabilities, as of Sep 2025, the value is 38.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.62 Cr. (Mar 2025) to 38.62 Cr., marking an increase of 2.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 14.97 Cr.. The value appears to be declining and may need further review. It has decreased from 15.29 Cr. (Mar 2025) to 14.97 Cr., marking a decrease of 0.32 Cr..
- For CWIP, as of Sep 2025, the value is 1.17 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 1.17 Cr., marking an increase of 1.17 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 22.48 Cr.. The value appears strong and on an upward trend. It has increased from 21.33 Cr. (Mar 2025) to 22.48 Cr., marking an increase of 1.15 Cr..
- For Total Assets, as of Sep 2025, the value is 38.62 Cr.. The value appears strong and on an upward trend. It has increased from 36.62 Cr. (Mar 2025) to 38.62 Cr., marking an increase of 2.00 Cr..
Notably, the Reserves (16.46 Cr.) exceed the Borrowings (3.72 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.07 | -1.70 | -3.22 | -3.15 | -1.90 | -1.95 | -3.31 | -6.14 | -3.87 | -2.26 | -5.51 | -1.12 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4.95 | 9.55 | 42.68 | 37.89 | 111.80 | 57.26 | 13.28 | 33.87 | 9.14 | 17.81 | 12.74 | 24.45 |
| Inventory Days | 1.97 | 32.35 | 19.39 | 21.47 | 16.45 | 16.50 | 21.19 | 21.95 | 23.75 | 16.75 | 13.09 | 45.72 |
| Days Payable | 0.07 | 5.34 | 13.72 | 0.13 | 95.65 | 59.47 | 12.83 | 33.71 | 73.24 | 33.22 | 9.56 | 5.19 |
| Cash Conversion Cycle | 6.85 | 36.57 | 48.35 | 59.23 | 32.60 | 14.29 | 21.63 | 22.11 | -40.36 | 1.34 | 16.27 | 64.99 |
| Working Capital Days | 13.31 | 37.52 | 33.25 | 34.56 | 22.14 | 10.94 | 9.57 | -14.20 | -34.31 | -7.31 | -4.07 | 48.67 |
| ROCE % | 6.25% | 11.98% | 8.94% | 13.76% | 13.64% | 10.95% | 7.77% | 6.54% | 4.26% | 3.30% | -10.00% | 4.24% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.44 | 0.67 | 0.02 | 0.19 | 0.37 |
| Diluted EPS (Rs.) | 1.44 | 0.67 | 0.02 | 0.19 | 0.37 |
| Cash EPS (Rs.) | 3.40 | 3.64 | 3.54 | 1.44 | 0.98 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.34 | 12.69 | 12.30 | 12.23 | 12.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.34 | 12.69 | 12.30 | 12.23 | 12.03 |
| Revenue From Operations / Share (Rs.) | 71.44 | 97.65 | 75.39 | 97.86 | 95.37 |
| PBDIT / Share (Rs.) | 2.80 | 1.13 | 4.12 | 2.04 | 1.69 |
| PBIT / Share (Rs.) | 0.83 | -1.84 | 0.60 | 0.79 | 1.08 |
| PBT / Share (Rs.) | 1.73 | 0.79 | 0.02 | 0.37 | 0.48 |
| Net Profit / Share (Rs.) | 1.44 | 0.66 | 0.01 | 0.18 | 0.37 |
| PBDIT Margin (%) | 3.92 | 1.15 | 5.46 | 2.08 | 1.77 |
| PBIT Margin (%) | 1.17 | -1.88 | 0.79 | 0.81 | 1.12 |
| PBT Margin (%) | 2.42 | 0.81 | 0.02 | 0.38 | 0.51 |
| Net Profit Margin (%) | 2.01 | 0.68 | 0.02 | 0.19 | 0.39 |
| Return on Networth / Equity (%) | 6.43 | 5.24 | 0.13 | 1.52 | 3.11 |
| Return on Capital Employeed (%) | 3.56 | -10.48 | 3.14 | 5.40 | 6.85 |
| Return On Assets (%) | 4.98 | 2.51 | 0.05 | 0.59 | 1.12 |
| Long Term Debt / Equity (X) | 0.01 | 0.13 | 0.22 | 0.19 | 0.29 |
| Total Debt / Equity (X) | 0.11 | 0.36 | 0.44 | 0.41 | 0.55 |
| Asset Turnover Ratio (%) | 2.87 | 3.41 | 2.42 | 3.01 | 3.42 |
| Current Ratio (X) | 2.82 | 0.88 | 0.87 | 0.50 | 0.84 |
| Quick Ratio (X) | 1.35 | 0.53 | 0.62 | 0.29 | 0.65 |
| Inventory Turnover Ratio (X) | 13.94 | 2.63 | 0.99 | 9.28 | 7.42 |
| Interest Coverage Ratio (X) | 8.99 | 2.12 | 7.75 | 5.32 | 3.12 |
| Interest Coverage Ratio (Post Tax) (X) | 1.75 | -3.69 | 1.12 | 1.58 | 1.78 |
| Enterprise Value (Cr.) | 40.05 | 27.54 | 18.24 | 14.60 | 12.26 |
| EV / Net Operating Revenue (X) | 0.44 | 0.28 | 0.24 | 0.14 | 0.12 |
| EV / EBITDA (X) | 11.25 | 24.31 | 4.43 | 7.14 | 7.25 |
| MarketCap / Net Operating Revenue (X) | 0.40 | 0.23 | 0.16 | 0.10 | 0.06 |
| Price / BV (X) | 1.30 | 1.81 | 1.04 | 0.84 | 0.49 |
| Price / Net Operating Revenue (X) | 0.40 | 0.23 | 0.16 | 0.10 | 0.06 |
| EarningsYield | 0.04 | 0.02 | 0.00 | 0.01 | 0.06 |
After reviewing the key financial ratios for Continental Seeds and Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 1.44, marking an increase of 0.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 1.44, marking an increase of 0.77.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.40. This value is within the healthy range. It has decreased from 3.64 (Mar 24) to 3.40, marking a decrease of 0.24.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.34. It has increased from 12.69 (Mar 24) to 22.34, marking an increase of 9.65.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.34. It has increased from 12.69 (Mar 24) to 22.34, marking an increase of 9.65.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.44. It has decreased from 97.65 (Mar 24) to 71.44, marking a decrease of 26.21.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.80. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 2.80, marking an increase of 1.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.83. This value is within the healthy range. It has increased from -1.84 (Mar 24) to 0.83, marking an increase of 2.67.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 0.79 (Mar 24) to 1.73, marking an increase of 0.94.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 2. It has increased from 0.66 (Mar 24) to 1.44, marking an increase of 0.78.
- For PBDIT Margin (%), as of Mar 25, the value is 3.92. This value is below the healthy minimum of 10. It has increased from 1.15 (Mar 24) to 3.92, marking an increase of 2.77.
- For PBIT Margin (%), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 10. It has increased from -1.88 (Mar 24) to 1.17, marking an increase of 3.05.
- For PBT Margin (%), as of Mar 25, the value is 2.42. This value is below the healthy minimum of 10. It has increased from 0.81 (Mar 24) to 2.42, marking an increase of 1.61.
- For Net Profit Margin (%), as of Mar 25, the value is 2.01. This value is below the healthy minimum of 5. It has increased from 0.68 (Mar 24) to 2.01, marking an increase of 1.33.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.43. This value is below the healthy minimum of 15. It has increased from 5.24 (Mar 24) to 6.43, marking an increase of 1.19.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.56. This value is below the healthy minimum of 10. It has increased from -10.48 (Mar 24) to 3.56, marking an increase of 14.04.
- For Return On Assets (%), as of Mar 25, the value is 4.98. This value is below the healthy minimum of 5. It has increased from 2.51 (Mar 24) to 4.98, marking an increase of 2.47.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.13 (Mar 24) to 0.01, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.36 (Mar 24) to 0.11, marking a decrease of 0.25.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.87. It has decreased from 3.41 (Mar 24) to 2.87, marking a decrease of 0.54.
- For Current Ratio (X), as of Mar 25, the value is 2.82. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 2.82, marking an increase of 1.94.
- For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has increased from 0.53 (Mar 24) to 1.35, marking an increase of 0.82.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 13.94. This value exceeds the healthy maximum of 8. It has increased from 2.63 (Mar 24) to 13.94, marking an increase of 11.31.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.99. This value is within the healthy range. It has increased from 2.12 (Mar 24) to 8.99, marking an increase of 6.87.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 3. It has increased from -3.69 (Mar 24) to 1.75, marking an increase of 5.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 40.05. It has increased from 27.54 (Mar 24) to 40.05, marking an increase of 12.51.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.44, marking an increase of 0.16.
- For EV / EBITDA (X), as of Mar 25, the value is 11.25. This value is within the healthy range. It has decreased from 24.31 (Mar 24) to 11.25, marking a decrease of 13.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.40, marking an increase of 0.17.
- For Price / BV (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.30, marking a decrease of 0.51.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 24) to 0.40, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Continental Seeds and Chemicals Ltd:
- Net Profit Margin: 2.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.56% (Industry Average ROCE: 16.97%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.43% (Industry Average ROE: 15.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 37.6 (Industry average Stock P/E: 34.28)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Seeds/Tissue Culture/Bio Technology | DTJ-114, DLF Tower B, Jasola, New Delhi Delhi 110025 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pravin Rastogi | Chairman & Managing Director |
| Mrs. Nidhi Gupta | Executive & Women Director |
| Mr. Sachin Rastogi | Executive Director |
| Mr. Prashant Rastogi | Independent Director |
| Mr. Gopal Krishan Sharma | Independent Director |
| Mr. Vivek Kumar Mathur | Independent Director |
FAQ
What is the intrinsic value of Continental Seeds and Chemicals Ltd?
Continental Seeds and Chemicals Ltd's intrinsic value (as of 08 January 2026) is ₹19.81 which is 6.11% lower the current market price of ₹21.10, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹28.9 Cr. market cap, FY2025-2026 high/low of ₹34.8/19.3, reserves of ₹16.46 Cr, and liabilities of ₹38.62 Cr.
What is the Market Cap of Continental Seeds and Chemicals Ltd?
The Market Cap of Continental Seeds and Chemicals Ltd is 28.9 Cr..
What is the current Stock Price of Continental Seeds and Chemicals Ltd as on 08 January 2026?
The current stock price of Continental Seeds and Chemicals Ltd as on 08 January 2026 is ₹21.1.
What is the High / Low of Continental Seeds and Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Continental Seeds and Chemicals Ltd stocks is ₹34.8/19.3.
What is the Stock P/E of Continental Seeds and Chemicals Ltd?
The Stock P/E of Continental Seeds and Chemicals Ltd is 37.6.
What is the Book Value of Continental Seeds and Chemicals Ltd?
The Book Value of Continental Seeds and Chemicals Ltd is 22.5.
What is the Dividend Yield of Continental Seeds and Chemicals Ltd?
The Dividend Yield of Continental Seeds and Chemicals Ltd is 0.00 %.
What is the ROCE of Continental Seeds and Chemicals Ltd?
The ROCE of Continental Seeds and Chemicals Ltd is 4.24 %.
What is the ROE of Continental Seeds and Chemicals Ltd?
The ROE of Continental Seeds and Chemicals Ltd is 2.87 %.
What is the Face Value of Continental Seeds and Chemicals Ltd?
The Face Value of Continental Seeds and Chemicals Ltd is 10.0.